Search for: "Elan Pharmaceuticals" Results 1 - 20 of 83
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2011, 8:55 pm by Patent Docs
Teva Pharmaceuticals USA Inc. 1:11-cv-00367; filed April 25, 2011 in the District Court of Delaware • Plaintiffs: Elan Corp. plc; Elan Pharma International Ltd. [read post]
15 Dec 2010, 11:16 pm by Ben Vernia
According to DOJ’s press release: Irish pharmaceutical manufacturer Elan Corporation PLC and its U.S. subsidiary Elan Pharmaceuticals Inc. [read post]
7 Sep 2009, 9:34 pm
Sandoz Inc. 2:09-cv-04513; filed September 1, 2009 in the District Court of New Jersey • Plaintiffs: King Pharmaceuticals Inc.; King Pharmaceuticals Research and Development, Inc.; Elan Corporation, PLC.; Elan Pharma International Ltd. [read post]
12 Jun 2011, 9:17 pm by Patent Docs
Elan Corp. et al. v. [read post]
1 Dec 2021, 1:29 pm by Kevin LaCroix
In the following guest post, Tony Kriesel, Claims Specialist with IQUW; Elan Kandel, a Member of the Bailey Cavalieri law firm; and James Talbert, an Associate at Bailey Cavalieri, take a look at the reasons for the pharmaceutical industry’s high securities litigation frequency experience and at the implications of the lawsuit frequency for pharmaceutical companies and their insurers. [read post]
18 Aug 2014, 12:53 pm by Steve Bainbridge
Alison Frankel reports: Everyone knows that the hedge fund SAC Capital, now known as Point72, made a bundle when it ditched shares of the pharmaceutical companies Wyeth and Elan based on inside... [[ This is a content summary only. [read post]
24 Sep 2007, 8:57 pm
Elan Corporation PLC v. [read post]
9 Feb 2017, 6:14 pm by Steven Boutwell
By William Kolarik The New Jersey Tax Court’s opinion in Elan Pharmaceuticals, Inc. v. [read post]
8 Jan 2010, 9:59 am by Sheppard Mullin
In a much anticipated decision, the Federal Circuit held yesterday that two pharmaceutical companies, Wyeth and Elan Pharma, were entitled to extended patent term adjustments because the U.S. [read post]
16 Dec 2010, 11:18 am by fraudfighters
Department of Justice announced that it had reached a settlement agreement with the Irish pharmaceutical manufacturer Elan Corporation, PLC to resolve civil and criminal allegations that the company unlawfully marketed the anti-seizure drug Zonegran for uses that were not approved by the Food and Drug Administration. [read post]
8 Jan 2007, 1:55 pm
King Pharmaceuticals (Westlaw cite is 2006 WL 3716920), and the case number is WDQ-04-3521A special thanks goes out to Sanjay Murthy for pointing out this case. [read post]
25 May 2011, 9:00 pm
Earlier this month, the Massachusetts-based drug firm Alkermes announced that it was buying the Irish pharmaceutical maker Elan Drug Technologies in a deal valued at roughly $960 million according to press reports. [read post]
20 Dec 2010, 2:34 pm by Phillips & Cohen
"Such illegal conduct by pharmaceutical companies also costs the government billions of dollars, and these civil settlements and the criminal plea agreement by Elan demonstrate that such conduct will not be tolerated. [read post]
9 Apr 2011, 7:59 am by Lawrence B. Ebert
Stephen Zavell, Senior Counsel , IP, Chevron CorporationAmi Patel Shah, Senior Patent Attorney, Intel CorporationAndrea Small, Director of IP, Legal, Elan Pharmaceuticals Inc.Ankur D. [read post]
9 Oct 2009, 9:11 am
Infineon Technologies AG, Infineon Technologies North America Corporation (patent infringement) 10/6: Elan Pharma International Ltd. and Jazz Pharmaceuticals Inc. v. [read post]